Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty
Ashish Shah, Dmitriy N FeldmanGreenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USAAbstract: Cardiovascular disease is the leading cause of death in the US. For patients with ST-elevation myocardial infarction (STEMI), urgent reperfusion o...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-02-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | http://www.dovepress.com/outcome-of-the-horizons-ami-trial-bivalirudin-enhances-long-term-survi-a9357 |